sales@angenesci.com
Login | Register
logo
Structures Search
Home Aminos 2-(Benzylamino)-2-oxoacetic acid

2-(Benzylamino)-2-oxoacetic acid

CAS No.:
6345-08-0
Catalog Number:
AG01FAS3
Molecular Formula:
C9H9NO3
Molecular Weight:
179.1727
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
25mg
1 week
United States
$163
- +
100mg
1 week
United States
$296
- +
Product Description
Catalog Number:
AG01FAS3
Chemical Name:
2-(Benzylamino)-2-oxoacetic acid
CAS Number:
6345-08-0
Molecular Formula:
C9H9NO3
Molecular Weight:
179.1727
MDL Number:
MFCD06740187
IUPAC Name:
2-(benzylamino)-2-oxoacetic acid
InChI:
InChI=1S/C9H9NO3/c11-8(9(12)13)10-6-7-4-2-1-3-5-7/h1-5H,6H2,(H,10,11)(H,12,13)
InChI Key:
GUZSZEGZZYGNJR-UHFFFAOYSA-N
SMILES:
O=C(C(=O)O)NCc1ccccc1
NSC Number:
51440
Properties
Complexity:
197  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
179.058g/mol
Formal Charge:
0
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
179.175g/mol
Monoisotopic Mass:
179.058g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
66.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1  
Literature
Title Journal
Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation. Bioorganic & medicinal chemistry letters 20100501
Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453). Journal of medicinal chemistry 20100408
Nonclinical safety evaluation of muraglitazar, a novel PPARalpha/gamma agonist. Toxicological sciences : an official journal of the Society of Toxicology 20071101
Muraglitazar: an agent for the treatment of type 2 diabetes and associated dyslipidemia. Drugs of today (Barcelona, Spain : 1998) 20050901
Properties